AngioDynamics, Inc. Business Development
AngioDynamics, Inc. (ANGO) reported Business Development of $5.40 million for the 0-month period ending 2013-12-05, per its 10-Q filed 2014-04-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessDevelopment · last filed 2014-04-09
- 2013-12-05: Business Development 0 month $5.40M.
| Period end | Business Development 0 month |
|---|---|
| 2013-12-05 | $5.40M 10-Q · filed 2014-04-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |